Public pharma is an alternative to our current, profit-driven pharmaceutical system that uses the public sector for drug research, development, and/or distribution. Join Connecticut’s #Insulin4All Chapter, T1International, and the Yale's Global Health Justice Partnership for a community conversation about public pharma in Connecticut. We will hear from patient advocates, legislators, and health services researchers about how public pharma can help address the problems of insulin inaccessibility facing people with diabetes, and the exciting opportunities for public pharma in our state!